Risk Intelligence
Delayed conversion of large deals into revenue
View Risks →Infosys reported Q3 FY24 revenue declined 1% YoY in constant currency, with operating margin at 20.5%, down 70bps sequentially due to salary hikes and the McCamish cyber incident.
✓ Verified against BSE filing
Infosys reported Q3 FY24 revenue declined 1% YoY in constant currency, with operating margin at 20.5%, down 70bps sequentially due to salary hikes and the McCamish cyber incident. Large deal TCV was strong at $3.2 billion (71% net new), contributing to a record $13.2 billion YTD. However, discretionary spending remains subdued, particularly in financial services and telecom, while cost efficiency and consolidation deals drive wins. Management tightened FY24 revenue guidance to 1.5%-2% CC (from 1%-2.5%), retaining margin guidance of 20%-22%. Generative AI traction is broad but not yet quantified. Risks include delayed conversion of large deals into revenue and sustained pressure on digital transformation programs.
इन्फोसिस ने तीसरी तिमाही में कमाई 1% घटी। मुनाफा 20.5% रहा, जो पिछली तिमाही से 0.7% कम है। इसकी वजह तनख्वाह बढ़ोतरी और साइबर हमला है। बड़े सौदों का कुल मूल्य 3.2 अरब डॉलर रहा, जिसमें 71% नए ग्राहकों से हैं। इस साल अब तक 13.2 अरब डॉलर के सौदे हुए हैं। लेकिन बैंक और टेलीकॉम क्षेत्रों में खर्च कम है। कंपनी ने इस साल की कमाई वृद्धि का अनुमान 1.5% से 2% तक रखा है। मुनाफा 20% से 22% के बीच रहेगा। नई तकनीक का असर अभी साफ नहीं है। बड़े सौदों से कमाई आने में देरी और डिजिटल बदलाव पर दबाव जोखिम हैं।
Delayed conversion of large deals into revenue
View Risks →Full transcript text is available on this route.
Read Transcript →Q3 large deal total contract value, with 71% net new, including one mega deal.
Highest ever large deal value for first three quarters of a fiscal year.
Continued decline in trailing twelve-month attrition, indicating improved retention.
Sequential improvement in utilization, with headroom to reach 84-85%.
Revised from previous 1%-2.5% range, reflecting Q3 performance and Q4 outlook.
Unchanged despite Q3 margin of 20.5%, with confidence from Project Maximus.
Multiple tracks including value-based selling, pyramid optimization, and GenAI expected to drive margin expansion over time.
Management indicated that the record large deal signings will support revenue acceleration in FY25, as ramp-ups are expected to materialize over the coming quarters.
Analysts raised concerns that large deal wins may not convert to revenue on time; management acknowledged but provided no specific timeline.
Digital transformation programs remain weak, with clients prioritizing cost takeout; no signs of recovery in Q3.
Analyst questioned if lower-margin cost deals signed recently could pressure margins; management downplayed but acknowledged historical pattern.
Third-party items now over 8% of revenue, potentially diluting margins if not managed; management expressed comfort but no target level.
Clients continue to cut discretionary and transformation projects, with no expected recovery in calendar 2024, which could further pressure revenue growth.
Mega deals are taking longer to start contributing revenue due to rebadging, regulatory approvals, and transition periods, potentially delaying growth inflection.
Compensation hikes effective November 1 and increased third-party pass-through costs could offset margin gains from Project Maximus.
Financial services, telecom, and retail continue to face headwinds, and any further deterioration could disproportionately impact Infosys given its exposure.
Mentioned in Q1 FY24, Q2 FY24
Compensation hikes effective November 1 and increased third-party pass-through costs could offset margin gains from Project Maximus.
Mentioned in Q1 FY24, Q2 FY24
Clients continue to cut discretionary and transformation projects, with no expected recovery in calendar 2024, which could further pressure revenue growth.
Revised from previous 1%-2.5% range, reflecting Q3 performance and Q4 outlook.
Analysts raised concerns that large deal wins may not convert to revenue on time; management acknowledged but provided no specific timeline.
View Risks →